Ubs Oconnor LLC Bristol Myers Squibb CO Transaction History
Ubs Oconnor LLC
- $2.23 Billion
- Q2 2025
A detailed history of Ubs Oconnor LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Ubs Oconnor LLC holds 40,000 shares of BMY stock, worth $1.78 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
40,000Holding current value
$1.78 Million% of portfolio
0.08%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding BMY
# of Institutions
2,662Shares Held
1.64BCall Options Held
22.4MPut Options Held
25.4M-
Vanguard Group Inc Valley Forge, PA195MShares$8.68 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.07 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$4.81 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.7MShares$4.22 Billion0.17% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA70.8MShares$3.15 Billion0.59% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $94.7B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...